Can rotablation be used to ablate a stent in a patient with a history of coronary artery disease and previous stent placement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rotablation Should NOT Be Used to Ablate a Previously Placed Stent

Rotational atherectomy is designed to modify inelastic atherosclerotic tissue and calcified plaque BEFORE stent placement, not to ablate stents themselves. The 2021 ACC/AHA/SCAI guidelines explicitly state that rotational atherectomy "excavates inelastic atherosclerotic tissue through the use of a diamond-tipped burr" and is used to "prepare" a lesion for stenting, not to treat stents 1.

Why Rotablation Cannot Ablate Stents

The fundamental mechanism of rotational atherectomy makes it incompatible with stent ablation:

  • Rotational atherectomy uses a diamond-tipped burr rotating at 140,000-180,000 rpm to pulverize atherosclerotic plaque and calcium 1
  • The device is specifically designed to selectively ablate inelastic tissue while theoretically sparing elastic vessel wall 1
  • Metal stents are neither atherosclerotic tissue nor calcium—they are permanent metallic scaffolds that cannot be "pulverized" by the rotablator burr 1

The Correct Clinical Indication for Rotablation

Rotational atherectomy has a Class 2a, Level B-R recommendation for fibrotic or heavily calcified lesions to improve procedural success BEFORE stent placement 1:

  • Use rotablation when lesions cannot be crossed by a balloon or adequately dilated before planned stenting 1
  • Calcium deposits thicker than 500 μm or involving >270° arc of the vessel on intravascular imaging predict the need for rotational atherectomy 1
  • The goal is to facilitate stent delivery and expansion in heavily calcified vessels 1

Management of In-Stent Restenosis

For patients with previous stent placement who develop restenosis, rotablation is controversial and generally NOT recommended 1:

  • The 2005 European Society of Cardiology guidelines explicitly state: "In general, we do not support the use of rotablation for in-stent restenosis" 1
  • While rotablation has been suggested for in-stent restenosis because tissue ablation might be more efficacious than balloon compression, this strategy remains controversial 1
  • The mechanism would be to ablate neointimal hyperplasia WITHIN the stent, not the stent itself 1

Alternative Approaches for Stented Vessels

When dealing with a patient who has a previously placed stent:

  • For in-stent restenosis: Consider drug-coated balloons (Class I, Level A recommendation from ESC) 2, 3
  • For underdeployed stents: Use high-pressure balloon angioplasty, not rotablation 1
  • For severe calcification adjacent to (not within) a stent: Rotablation may be used to prepare the adjacent native vessel before extending stent coverage 4, 5

Critical Safety Considerations

Attempting to use rotablation on a stent would create severe complications:

  • Risk of stent fracture, embolization, or vessel perforation
  • The diamond burr cannot effectively ablate metal and would likely cause device failure
  • Increased risk of no-reflow phenomenon and periprocedural myocardial infarction 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Drug-Coated Balloons for De Novo Coronary Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Drug-Coated Balloons in Cardiovascular Interventions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.